Literature DB >> 1291660

Epidemiology and prevention of blood pressure-related renal disease.

P K Whelton1, T V Perneger, F L Brancati, M J Klag.   

Abstract

AIM: To examine the relationship between blood pressure and end-stage renal disease.
METHOD: Review of recent reports on blood pressure in relation to renal function.
BACKGROUND: The incidence and prevalence of treated end-stage renal disease are increasing progressively in economically developed countries. To combat this problem, the treatment of established end-stage renal disease must be complemented by strategies to treat and prevent risk factors for the development of renal failure.
RESULTS: Severe hypertension and malignant hypertension are well accepted as risk factors for renal insufficiency. Recent reports suggest a strong relationship between blood pressure and renal function, throughout the entire range of blood pressure. Most blood pressure-related renal disease can probably be attributed to mild hypertension or a high normal blood pressure.
CONCLUSIONS: Additional clinical trials are needed to assess the value of different antihypertensive drugs and different levels of blood pressure control in preserving renal function in subjects at risk of blood pressure-related renal disease. Primary prevention of hypertension may be an important complement to the treatment of established hypertension in reducing the burden of renal disease in the community.

Entities:  

Mesh:

Year:  1992        PMID: 1291660

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

1.  A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study.

Authors:  Sue Rutherford; Guowen Cai; Juan C Lopez-Alvarenga; Jack W Kent; V Saroja Voruganti; J Michael Proffitt; Joanne E Curran; Mathew P Johnson; Thomas D Dyer; Jeremy B Jowett; Raul A Bastarrachea; Larry D Atwood; Harald H H Goring; Jean W Maccluer; Eric K Moses; John Blangero; Anthony G Comuzzie; Shelley A Cole
Journal:  Am J Hum Genet       Date:  2007-08-20       Impact factor: 11.025

2.  Social context as an explanation for race disparities in hypertension: findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study.

Authors:  Roland J Thorpe; Dwayne T Brandon; Thomas A LaVeist
Journal:  Soc Sci Med       Date:  2008-08-12       Impact factor: 4.634

3.  The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.

Authors:  T W Wilson; Y Lacourcière; C C Barnes
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

4.  Novel blood pressure and pulse pressure estimation based on pulse transit time and stroke volume approximation.

Authors:  Joonnyong Lee; JangJay Sohn; Jonghyun Park; SeungMan Yang; Saram Lee; Hee Chan Kim
Journal:  Biomed Eng Online       Date:  2018-06-18       Impact factor: 2.819

5.  Association Between Obesity and Blood Pressure in Common Korean People.

Authors:  Nam Lyong Kang
Journal:  Vasc Health Risk Manag       Date:  2021-06-28

6.  Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults.

Authors:  Fawzi A Babiker; Lamia A Elkhalifa; Mohamed E Moukhyer
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

7.  The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.

Authors:  Robert A Phillips; Robert A Kloner; Richard H Grimm; Myron Weinberger
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.